» Articles » PMID: 11443094

Roles of LcrG and LcrV During Type III Targeting of Effector Yops by Yersinia Enterocolitica

Overview
Journal J Bacteriol
Specialty Microbiology
Date 2001 Jul 10
PMID 11443094
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Yersinia enterocolitica target effector Yop proteins into the cytosol of eukaryotic cells by a mechanism requiring the type III machinery. LcrG and LcrV have been suggested to fulfill essential functions during the type III targeting of effector Yops. It is reported here that knockout mutations of lcrG caused mutant yersiniae to prematurely secrete Yops into the extracellular medium without abolishing the type III targeting mechanism (Los phenotype [loss of type III targeting specificity]). Knockout mutations in lcrV reduced type III targeting of mutant yersiniae but did not promote secretion into the extracellular medium (Not [no type III targeting]). However, knockout mutations in both genes caused DeltalcrGV yersiniae to display a Los phenotype similar to that of strains carrying knockout mutations in lcrG alone. LcrG binding to LcrV resulted in the formation of soluble LcrGV complexes in the bacterial cytoplasm. Membrane-associated, bacterial-surface-displayed or -secreted LcrG could not be detected. Most of LcrV was located in the bacterial cytoplasm; however, small amounts were secreted into the extracellular medium. These data support a model whereby LcrG may act as a negative regulator of type III targeting in the bacterial cytoplasm, an activity that is modulated by LcrG binding to LcrV. No support could be gathered for the hypothesis whereby LcrG and LcrV may act as a bacterial surface receptor for host cells, allowing effector Yop translocation across the eukaryotic plasma membrane.

Citing Articles

Pathogenicity and virulence of .

Seabaugh J, Anderson D Virulence. 2024; 15(1):2316439.

PMID: 38389313 PMC: 10896167. DOI: 10.1080/21505594.2024.2316439.


PathFams: statistical detection of pathogen-associated protein domains.

Lobb B, Tremblay B, Moreno-Hagelsieb G, Doxey A BMC Genomics. 2021; 22(1):663.

PMID: 34521345 PMC: 8442362. DOI: 10.1186/s12864-021-07982-8.


The type III secretion system needle, tip, and translocon.

Dey S, Chakravarty A, Biswas P, De Guzman R Protein Sci. 2019; 28(9):1582-1593.

PMID: 31301256 PMC: 6699086. DOI: 10.1002/pro.3682.


SsaV Interacts with SsaL to Control the Translocon-to-Effector Switch in the SPI-2 Type Three Secretion System.

Yu X, Grabe G, Liu M, Mota L, Holden D mBio. 2018; 9(5).

PMID: 30279280 PMC: 6168863. DOI: 10.1128/mBio.01149-18.


Bacterial type III secretion systems: a complex device for the delivery of bacterial effector proteins into eukaryotic host cells.

Wagner S, Grin I, Malmsheimer S, Singh N, Torres-Vargas C, Westerhausen S FEMS Microbiol Lett. 2018; 365(19).

PMID: 30107569 PMC: 6140923. DOI: 10.1093/femsle/fny201.


References
1.
Sarker M, Neyt C, Stainier I, Cornelis G . The Yersinia Yop virulon: LcrV is required for extrusion of the translocators YopB and YopD. J Bacteriol. 1998; 180(5):1207-14. PMC: 107009. DOI: 10.1128/JB.180.5.1207-1214.1998. View

2.
Iriarte M, Sory M, Boland A, Boyd A, Mills S, Lambermont I . TyeA, a protein involved in control of Yop release and in translocation of Yersinia Yop effectors. EMBO J. 1998; 17(7):1907-18. PMC: 1170537. DOI: 10.1093/emboj/17.7.1907. View

3.
Sarker M, Sory M, Boyd A, Iriarte M, Cornelis G . LcrG is required for efficient translocation of Yersinia Yop effector proteins into eukaryotic cells. Infect Immun. 1998; 66(6):2976-9. PMC: 108297. DOI: 10.1128/IAI.66.6.2976-2979.1998. View

4.
Lee V, Anderson D, Schneewind O . Targeting of Yersinia Yop proteins into the cytosol of HeLa cells: one-step translocation of YopE across bacterial and eukaryotic membranes is dependent on SycE chaperone. Mol Microbiol. 1998; 28(3):593-601. DOI: 10.1046/j.1365-2958.1998.00822.x. View

5.
Tardy F, Homble F, Neyt C, Wattiez R, Cornelis G, Ruysschaert J . Yersinia enterocolitica type III secretion-translocation system: channel formation by secreted Yops. EMBO J. 1999; 18(23):6793-9. PMC: 1171741. DOI: 10.1093/emboj/18.23.6793. View